プレマーケット: 2.94 -0.05 -1.67%

Verastem Inc (VSTM)

Verastem Inc (VSTM) 最新ニュース

Verastem Inc (VSTM)

Verastem Inc (VSTM) 最新ニュース

Nantahala Capital Management LLC Purchases Shares of 400,000 Verastem, Inc. (NASDAQ:VSTM) - MarketBeat

Verastem's SWOT analysis: oncology firm's stock faces pivotal phase - Investing.com

Verastem (NASDAQ:VSTM) Now Covered by Analysts at Guggenheim - MarketBeat

Verastem, Inc. (NASDAQ:VSTM) Receives Consensus Rating of "Buy" from Analysts - MarketBeat

Verastem CFO sells shares worth $257 to cover tax obligations By Investing.com - Investing.com Australia

Verastem CFO sells shares worth $257 to cover tax obligations By Investing.com - Investing.com South Africa

Verastem CFO sells shares worth $257 to cover tax obligations By Investing.com - Investing.com Canada

Verastem CFO sells shares worth $257 to cover tax obligations - Investing.com India

Verastem CFO sells shares worth $257 to cover tax obligations - Investing.com

Financial Analysis: Verastem Inc (VSTM)’s Ratios Unveil Key Insights - The Dwinnex

Does Verona Pharma Plc ADR (NASDAQ: VRNA) Still Look Hot This Week? - Stocks Register

Verona Pharma Plc ADR (VRNA) deserves closer scrutiny - US Post News

Evan/ Fa Jones Sells 5,173 Shares of Veracyte, Inc. (NASDAQ:VCYT) Stock - Defense World

Stock Surge: Viridian Therapeutics Inc (VRDN) Closes at 22.30, Marking a -0.89 Increase/Decrease - The Dwinnex

Are Smart Investors Making the Right Decision? Verastem Inc (VSTM) - SETE News

Victory Capital Management Inc. Makes New $527,000 Investment in Savara Inc (NASDAQ:SVRA) - Defense World

Verastem CEO sells shares worth $513 to cover tax obligations By Investing.com - Investing.com South Africa

Verastem director sells shares worth $365 to meet tax obligations By Investing.com - Investing.com Australia

Verastem director Brian Stuglik sells shares worth $937 By Investing.com - Investing.com South Africa

Verastem CEO sells shares worth $513 to cover tax obligations By Investing.com - Investing.com Australia

Verastem director Brian Stuglik sells shares worth $937 By Investing.com - Investing.com Australia

Verastem director sells shares worth $365 to meet tax obligations - Investing.com India

Verastem director sells shares worth $365 to meet tax obligations By Investing.com - Investing.com Canada

Verastem CEO sells shares worth $513 to cover tax obligations - Investing.com India

Verastem director sells shares worth $365 to meet tax obligations - Investing.com

Verastem CEO sells shares worth $513 to cover tax obligations By Investing.com - Investing.com Canada

Verastem CEO sells shares worth $513 to cover tax obligations - Investing.com

Verastem CEO sells shares worth $513 to cover tax obligations By Investing.com - Investing.com UK

Its Stock Has Paid Off Big Time For Valvoline Inc - SETE News

Resolute Capital Asset Partners LLC Invests $723,000 in Verona Pharma plc (NASDAQ:VRNA) - Defense World

Market Resilience: Verona Pharma Plc ADR (VRNA) Finishes Strong at 29.23, Up 0.14 - The Dwinnex

Verastem CEO sells shares worth $688 to cover taxes By Investing.com - Investing.com Australia

Verastem director sells company shares worth $803 By Investing.com - Investing.com Australia

Verastem director Brian Stuglik sells shares worth $1,680 By Investing.com - Investing.com Australia

Veracyte (NASDAQ:VCYT) Reaches New 52-Week High at $33.49 - Defense World

Verastem CEO sells shares worth $688 to cover taxes By Investing.com - Investing.com South Africa

Verastem director Brian Stuglik sells shares worth $1,680 By Investing.com - Investing.com South Africa

Verastem director sells company shares worth $803 By Investing.com - Investing.com South Africa

Verastem CEO sells shares worth $688 to cover taxes By Investing.com - Investing.com Canada

Verastem director sells company shares worth $803 By Investing.com - Investing.com Canada

Verastem director Brian Stuglik sells shares worth $1,680 - Investing.com India

Verastem director Brian Stuglik sells shares worth $1,680 By Investing.com - Investing.com Canada

Verastem director Brian Stuglik sells shares worth $1,680 - Investing.com

Verastem director sells company shares worth $803 By Investing.com - Investing.com UK

Valvoline Inc [VVV] Insider Activity: An Update for Investors - Knox Daily

Verastem director sells company shares worth $803 - Investing.com

Veracyte Inc (VCYT) Becoming More Attractive for Investors - Knox Daily

Is it possible to buy Verona Pharma Plc ADR(VRNA) shares at a good price now? - US Post News

Savara (NASDAQ:SVRA) Stock Price Up 6% - MarketBeat

What is Verona Pharma Plc ADR (VRNA) Stock Return on Shareholders’ Capital? - SETE News

Veracyte (NASDAQ:VCYT) Reaches New 1-Year High at $33.49 - MarketBeat

Vera Bradley Second Quarter 2025 Earnings: Misses Expectations - Simply Wall St

Vera Bradley Misses Q2 Earnings and Revenue Estimates - InkFreeNews.com

Viridian says thyroid eye disease drug effective in reducing symptoms - MSN

Examining Verastem Inc (VSTM) stock is warranted - US Post News

Verastem Oncology to Present at the 2024 Cantor Global Healthcare Conference - StockTitan

Verastem Oncology to Present Mature RAMP 201 Data in Low-Grade Serous Ovarian Cancer at the International Gynecologic Cancer Society 2024 Annual Meeting - StockTitan

Verastem Oncology to Present Mature RAMP 201 Data in Low-Grade Serous Ovarian Cancer at the International Gynecologic Cancer Society 2024 Annual Meeting - Business Wire

Verastem’s Path To FDA Approval: High-Risk, High-Reward Oncology Opportunity (NASDAQ:VSTM) - Seeking Alpha

Verastem Inc [VSTM] President and CEO makes an insider purchase of 3,245 shares worth 7009.0. - Knox Daily

Verastem Oncology and STAAR Ovarian Cancer Foundation Establish the Inaugural Low-Grade Serous Ovarian Cancer (LGSOC) Awareness Day on September 9, 2024 - StockTitan

Verastem, Inc. (NASDAQ:VSTM) Given Average Recommendation of "Buy" by Brokerages - MarketBeat

Verastem Inc’s latest rating changes from various analysts - Knox Daily

Verastem, Inc. (NASDAQ:VSTM) Sees Significant Decrease in Short Interest - Defense World

Verastem, Inc. (NASDAQ:VSTM) Short Interest Down 18.9% in July - MarketBeat

Verastem (NASDAQ:VSTM) Price Target Lowered to $15.00 at Truist Financial - Defense World

Verastem (NASDAQ:VSTM) PT Lowered to $7.00 - Defense World

Vanguard Group Inc. Acquires 10,678 Shares of Verastem, Inc. (NASDAQ:VSTM) - Defense World

Truist Financial Lowers Verastem (NASDAQ:VSTM) Price Target to $15.00 - MarketBeat

Truist cuts Verastem stock target, keeps buy rating on future performance - Investing.com UK

Verastem (NASDAQ:VSTM) Upgraded by StockNews.com to Hold - Defense World

Verastem (NASDAQ:VSTM) Raised to "Hold" at StockNews.com - MarketBeat

HC Wainwright Cuts Verastem (NASDAQ:VSTM) Price Target to $7.00 - MarketBeat

VSTMに似た銘柄